Healthcare Professionals’ Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease

Lignende værker

• Alignment between outcomes and minimal clinically important differences in the Dutch type 2 diabetes mellitus guideline and healthcare professionals’ preferences
  af: Dankers, Marloes, et al.
  Udgivet: (2021)
• Commentary: “Healthcare Professionals’ Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease” by Dankers M et al. in Frontiers in Pharmacology 2020; 10: 1519
  af: Alma, Harma, et al.
  Udgivet: (2020)
• The occurence and healthcare cost of acute exacerbations in patients with chronic obstructive pulmonary disease (COPD) managed in Dutch general practice
  af: Schermer, Tjard, et al.
  Udgivet: (2002)
• Use of Opioids Increases With Age in Older Adults: An Observational Study (2005–2017)
  af: Weesie, Yvette M., et al.
  Udgivet: (2020)
• Are component endpoints equal? A preference study into the practice of composite endpoints in clinical trials
  af: Vaanholt, Melissa C.W., et al.
  Udgivet: (2018)